Best stocks to buy today India for short term in india 2025
1. Choice International Ltd
Choice International Ltd showcased strong financial performance in Q1 FY25, with revenue up 48% and PAT increasing by 51%. EBITDA margin improved, and the business saw robust growth across Demat accounts, AUM, and insurance. Technical indicators suggest bullish momentum, making it an attractive option for short-term investors. However, high valuation, negative cash flow, and elevated leverage present potential risks. Always conduct your own research or consult a financial advisor before investing.
2. Hindustan Copper Ltd
Hindustan Copper Ltd (NSE: HINDCOPPER) shows strong short-term investment potential. Q4 FY25 revenue surged 29% to ₹731.4 crore, with net profit up 52% to ₹189.5 crore. FY25 also saw impressive 21% revenue growth and 59% net profit increase, along with a ₹1.46 dividend. Technically, the stock is bullish, trading above key moving averages with a strong MACD. While the RSI and Stochastic Oscillator indicate potential overbought conditions, suggesting a possible short-term correction, its overall financial and technical strength makes it a noteworthy consideration. Investors should monitor for these technical signals.
3. Alivus Life Sciences Ltd
Alivus Life Sciences Ltd (formerly Glenmark Life Sciences) shows strong short-term investment potential. Q4 FY25 saw revenue up 21.1% YoY to ₹6,496 million and PAT at ₹1,419 million, reflecting solid profitability. Annually, FY25 revenue grew 4.54% and net profit 3.13%. With a P/E ratio at a 34% discount to the industry median and a high promoter holding (74.99%), the company exhibits sound financial health. Specializing in APIs for chronic therapeutic areas, Alivus maintains a strong market position. While its P/B ratio is at a premium, consistent growth and robust metrics make it a compelling option.
4. Poly Medicure Ltd
Poly Medicure Ltd (NSE: POLYMED), a leading Indian medical device manufacturer, demonstrated robust financial performance in FY25. Revenue increased 22.6% to ₹1,758.95 crore, and net profit (PAT) surged 31% to ₹338.55 crore. Q4 FY25 also showed strong growth, with revenue up 16.6% and net profit up 34.4%.
The company achieved a 27.1% EBITDA margin, showcasing improved operational efficiency. Exports grew by 24% and domestic revenue by 19%, indicating broad-based strength. With a low debt-to-equity ratio of 0.07 and healthy liquidity, Poly Medicure is financially stable. The launch of drug-eluting stents signals strategic product expansion. While the P/E ratio is 67.62, the company’s consistent growth and strong fundamentals position it well for the future.
5. BLS International Services Ltd
BLS International Services Ltd (NSE: BLS) exhibited exceptional FY25 financial performance, making it a strong short-term investment candidate. Revenue surged 30.8% YoY to ₹2,193.3 crore, with net profit (PAT) jumping 65.7% to ₹539.6 crore. EBITDA impressively grew 82.1%, expanding its margin to 28.7%. Both Visa & Consular and Digital Services segments showed robust growth. With strong ROE (34.6%) and ROCE (32.9%), BLS International demonstrates operational efficiency and market leadership. While the P/E ratio is 32.9, its consistent growth across segments makes it a compelling option in the tech-enabled services sector. Remember to research independently before investing.
6. C.E. Info Systems Ltd.
C.E. Info Systems Ltd (MapmyIndia) showcased robust FY25 financial growth. Full-year revenue increased 22% to ₹463.3 crore (from ₹379 crore in FY24), with net profit rising 10% to ₹147.6 crore (from ₹134.4 crore). Q4 FY25 alone saw revenue jump 34% to ₹143.5 crore and net profit climb 28% to ₹49 crore.
The company maintains a debt-free status and strong liquidity. While EBITDA margin for the nine-month period dipped slightly, the company’s strong ROE (23%) and ROCE (25.78%) highlight efficiency. Trading at a high P/E (73.16) and P/B (15.71) suggests premium valuations. Investors should weigh these factors and conduct further due diligence.
Disclaimer:
The stocks listed above are not investment recommendations. They are shared for informational and educational purposes only. Please do your own thorough research or consult a certified financial advisor before making any investment decisions. Investing in the stock market involves risks, and past performance is not indicative of future results.
